Nanotechnology Companies in Canada

Develops enabling nucleic acid-based technology applications, aimed at large biosensor/molecular diagnostics, therapeutics, and energy generation/management markets.

Developer, manufacturer and distributor of innovative sample preparation devices for high sensitive mass spectrometry and liquid chromatography.

ALFT provides unique, patented capability to deliver proven, cost-effective and portable soft X-ray sources facilitating and enabling advancements in the research and development of new applications spanning a broad range of industries; including medical imaging, biotechnology, nanotechnology, genomics, proteomics, and environmental and life sciences.

AlphaRx is a specialty pharmaceutical company utilizing proprietary site-specific nanoparticulate drug delivery systems to develop novel formulations of drugs that are insoluble or poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method.

American Dye Source, Inc. is a manufacturer of high quality materials for many different applications.

American Dye Source, Inc. is a manufacturer of high quality materials for many different applications.

Specializes in the design and fabrication of nanometer scale devices using electron-beam lithography (EBL), reactive ion etching, electroplating and thin film deposition as its core technologies.

Supplies high quality, calibration systems for atomic force microscopy imaging.

The core of the company's product line is their proprietary Diffractive Optics Technology - or dot™ - which combines two proven technologies - the diffraction of light and immobilized capture surfaces - to provide a simple, sensitive, and cost-effective technique for the real-time detection of biomolecular interactions and immunoassays without the use of labels.

Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).

Develops image-based, particle analysis technology.

The company has developed a process to utilize nanoscale properties by first functionalizing nanoparticles and then incorporating them into a base material (polymers, metals, ceramics or composites).

CCG is a software company that strives to provide state of the art applications in Drug Discovery to Pharmaceutical, Biotech and Academic researchers.

A global investment information firm with a sector specific focus on nanotechnology. Manages the CCM Nanotechnology Index.

Cronus Capital Markets (CCM) is a global investment information firm with one focus area on nanotechnology.